nivolumab,ipilimumab,pembrolizumab
bms,merck,roche
['nsclc', 'pemetrexed', 'sclc', 'ct041', 'pembro']
 as a nsclc st 4 non-sq braf v600e pt, i was randomized to no-treatment arm of nct04157985 out of after a year of pembro/pemetrexed. doing well 16 mos later. grateful for these studies.
At-home parent, Sg 4 NSCLC BRAFv600e dx 2019, mom of 4, @Stanford alum, Pittsburgh is home